Gambler and Ken: Cyrus is a clear improvement over Nader, but given what CYDY shareholders have had to stomach since 2020, the fact that Cyrus, with almost a year at the helm, and with plenty of time to write out (as opposed to the necessity of speaking spontaneously) one of his very infrequent statements/reports, was incapable of drafting a coherent paragraph addressing the status of the clinical hold for HIV is extremely disappointing. Likewise, if he mentioned Keytruda without a reasonable basis for doing so, that would be reminiscent of Nader's unscrupulous pumping schemes -- a very chilling prospect.

If Cyrus thinks he can simply maintain radio silence until he conducts another confusing conference call at the end of June without the sp and shareholder confidence plummeting, I suspect he is miscalculating.

I sincerely hope that Cyrus is reading this board and resolves to do better by his shareholders in communicating the ongoing status of issues central to the future of the company and LL.